PromarkerD US Market Update Proteomics International rescinds PromarkerD exclusive licence deal with PrismHealthDx in US – negotiations brought forward with new tier 1 partners New immunoassay technology platform to accelerate PromarkerD rollout in US Clinical samples for first phase of CDx collaborative study received from Janssen Research & Development, LLC Key Opinion Leader (KOL) engagement to drive US demand for PromarkerD
Ann: PromarkerD US market update, page-3
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
56.5¢ |
Change
-0.035(5.83%) |
Mkt cap ! $74.01M | |||
| Open | High | Low | Value | Volume |
| 60.0¢ | 60.0¢ | 56.5¢ | $169.1K | 294.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13665 | 56.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 59.5¢ | 12245 | 1 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |